Once again, Tessella is proudly sponsoring this years’ Bio-IT Best Practice Awards 2010, being held at the World Trade Centre, Boston, MA, USA on April 21, 2010 in conjunction with Bio-IT’s World Conference and Expo 2010.
Established in 2003, the award programme recognizes teams in industry and academia for their outstanding innovations and excellence in the enabling [...]
Kevin Davies, Editor-in-Chief, Bio-IT and Tessella’s Dr Andrew Chadwick, Principle Consultant, Life Sciences and Health Care discuss Translational Medicine. Listen to this podcast and learn about:
Effective, ethical approaches to trial design that harness incompletely validated predictive and prognostic biomarkers
Ways to improve the value of image information and other rich data
The tradeoffs to expect in using [...]
By Tom Parke
The US Food and Drug Administration (FDA) end-of-Phase 2a (EOP2A) meeting guidance issued on the September 2009 emphasises the value of the greater use of trial simulation and alternative design strategies in the clinical trials design process. The FDA’s primary purpose of an EOP2A meeting is to select the dosing regime and design [...]
BOSTON, Nov. 2, 2009 (GLOBE NEWSWIRE) — AG Mednet, the world’s largest diagnostic imaging network, announced today that more than 2000 users around the world have been credentialed to access and use its electronic diagnostic image submission platform…read more
Tessella are proud corporate sponsors of the Accelerating Development and Advancing Personalised Therapy 2009 (ADAPT 2009) being held at the Grand Hyatt, Washington DC on September 22-25 2009. This event features eight meetings with in-depth coverage of clinical trials, personalized medicine, cancer therapy, and biomarker development. This event was developed as the primary platform where these [...]
Adaptive designs are an exciting development that allows drug companies to better select doses, potentially bring novel therapies to the market faster, and provide real savings. While currently growing in popularity, Bayesian adaptive designs are still at the early adoption stage. We believe this situation will change radically and quickly when the first adaptive trial [...]
Tessella news Spring/Summer 2009 edition is available for download
In this edition
R&D IT strategy: the cavalry’s coming
Science and technology based organizations must adapt to ever changing market dynamics and fierce competition. Despite these waves of change, your organization’s R&D success relies on the implementation of a stable and coherent IT strategy.
Modelling sun sensor performance for TNO
When [...]
As pharma IT groups face tightening budgets and loosening ties between research areas, is an IT strategy spanning multiple research areas still a meaningful aim…read more
Tessella demonstated its Crystallographic Information System (CrysIS) at PSDI 2008, the annual Protein Structure Determination in Industry conference for structural biologists working in the pharmaceutical industry.
CrysIS manages the data and workflow of X-Ray protein crystallography from a request for a protein-compound, through the experiment and the final deposition of a protein-ligand structure, and the subsequent exploitation of [...]
Dr Michael D. O’Shea delivered a successful presentation at the Informatics & Data Visualisation conference, held on the 10th and 11th of March 2008, in Winchester UK.
His lecture described a software system where analytical sample registration, analytical LC, MS, and data processing selection and configuration, processing, and reporting were implemented through a single unified interface, [...]
